Senior business figures turned to former PM Kevin Rudd to intervene in bringing forward Australia's Pfizer vaccine supply
Laura Tingle - 12 July 2021
1/3
The bringing forward of millions of Pfizer vaccine doses last week followed a back channels intervention eight days earlier by a high-powered network which included a senior business figure despairing of the government's failure to secure enough vaccine supplies, and a former prime minister.
The revelation comes amid continuing controversy, and conflicting reports, about delays and shortcomings in Australia's vaccine supplies, and why Australia is currently only contracted for 40 million Pfizer doses this year.
With changing health advice about the AstraZeneca vaccine, Pfizer is the preferred vaccine for Australians under 60 until they are supplemented with supplies of the Moderna vaccine later in the year.
A spokesman for Health Minister Greg Hunt said on Sunday that the bring forward was a result of government negotiations conducted with Pfizer Australia.
In late June, senior Australian business figures based in the United States had discussed making contact with the vaccine manufacturer Pfizer to see whether it was possible for Australia to get earlier access to larger supplies of the Pfizer vaccine as the COVID-19 Delta variant emerged in Australia.
This came amid continuing reports that Australia had bungled its negotiations with the company in talks going back to June and July last year which displayed a "rude, dismissive and penny pinching" approach, according to one source.
Australia eventually signed a deal for just 10 million Pfizer doses in November 2020, four months behind other countries.
Health Department officials have flatly denied many of these reports, but the businessmen in the US who had connections with Pfizer were hearing even more graphic accounts of how badly offended the company had been by the response to its early approaches to Australia last year when it offered access to what is now to be a crucial part of our vaccine coverage.
As a result, one very senior Australian businessman — whose identity is known to the ABC but who wishes to remain anonymous — held two meetings with senior Pfizer executives in late June, only to be rebuffed.
Senior Pfizer executives told the businessman that if Australia was to make a more serious effort, after its treatment at the hands of relatively junior bureaucrats, it would have to come from much higher up, expressing their astonishment that Prime Minister Scott Morrison had not directly spoken to the Pfizer chairman and chief executive Albert Bourla, as former Israeli Prime Minister Benjamin Netanyahu had done on multiple occasions.
The executives suggested that, in the absence of Mr Morrison, former Australian prime minister Kevin Rudd — who was known to them because of his work in the United States as head of the New York-based Asia Society — may have some influence.
The network of businessmen contacted Mr Rudd and set up an introduction to Dr Bourla. A Zoom meeting was arranged on June 30. Mr Rudd sent a text message to Mr Morrison to tell him he was going to make the call, making clear he would be representing himself as a concerned Australian and not in any way as an emissary from the government.
(continued)